DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test
Introduction
The DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test is a vital diagnostic tool for identifying deficiencies in the Dihydropyrimidine Dehydrogenase (DPD) enzyme. This enzyme plays a crucial role in the metabolism of certain chemotherapy drugs, and its deficiency can lead to severe side effects in patients undergoing cancer treatment. Understanding your genetic predisposition through this test can significantly improve treatment outcomes and minimize adverse effects.
What the Test Measures
This genetic test evaluates the presence of mutations in the DPYD gene, which is responsible for producing the DPD enzyme. By identifying these mutations, healthcare providers can assess a patient’s risk of DPD deficiency, which is critical for safe and effective chemotherapy management.
Who Should Consider This Test
Patients who are candidates for chemotherapy, especially those with a family history of adverse reactions to chemotherapy drugs, should consider the DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test. Symptoms of DPD deficiency may include:
- Severe toxicity from chemotherapy
- Unexplained severe side effects
- Family history of metabolic disorders
Benefits of Taking the Test
Taking the DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test offers numerous benefits:
- Personalized treatment plans based on genetic makeup
- Reduced risk of severe side effects from chemotherapy
- Informed decision-making regarding cancer treatment
Understanding Your Results
Results from the DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test will indicate whether you carry mutations in the DPYD gene. A genetic counselor will help interpret your results and discuss potential implications for your treatment options.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a clinical history and a genetic counseling session are recommended to draw a pedigree chart of family members affected by Dihydropyrimidine Dehydrogenase deficiency.
Book Your Test Today!
We have branches across Kenya, including Nairobi, Mombasa, and Kisumu, and offer home sample collection services. To book the DPYD Gene Dihydropyrimidine Dehydrogenase Deficiency NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Take the first step towards personalized healthcare today!
